SOUTHBOROUGH, MA – July 13, 2015 – Veristat, a full service Clinical Research Organization (CRO), announced today that it has completed the move of its corporate headquarters to Southborough, Massachusetts. As previously announced, the move was driven by Veristat’s rapid growth in response to the increased demand for full-service clinical research offerings by its pharmaceutical and biotechnology clients.
Input Will Drive Trial Design for Lead Cancer Stem Cell-Targeting Program
September 10, 2013 - Veristat, a leading, Boston-based clinical research organization today announced its advisory role on the implementation of an adaptive enrichment trial design for Verastem, Inc. (NASDAQ: VSTM).